Display options
Cite
Friesen EL, De Snoo ML, Rajendran L, et al. Chaperone-Based Therapies for Disease Modification in Parkinson's Disease. Parkinsons Dis. 2017;2017:5015307doi: 10.1155/2017/5015307.
Friesen, E. L., De Snoo, M. L., Rajendran, L., Kalia, L. V., & Kalia, S. K. (2017). Chaperone-Based Therapies for Disease Modification in Parkinson's Disease. Parkinson's disease, 20175015307. https://doi.org/10.1155/2017/5015307
Friesen, Erik L, et al. "Chaperone-Based Therapies for Disease Modification in Parkinson's Disease." Parkinson's disease vol. 2017 (2017): 5015307. doi: https://doi.org/10.1155/2017/5015307
Friesen EL, De Snoo ML, Rajendran L, Kalia LV, Kalia SK. Chaperone-Based Therapies for Disease Modification in Parkinson's Disease. Parkinsons Dis. 2017;2017:5015307. doi: 10.1155/2017/5015307. Epub 2017 Aug 21. PMID: 28913005; PMCID: PMC5585656.
Copy Download .nbib Format: NLM
Share it on

Parkinsons Dis. 2017;2017:5015307. doi: 10.1155/2017/5015307. Epub 2017 Aug 21.

Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Parkinson's disease

Erik L Friesen, Mitch L De Snoo, Luckshi Rajendran, Lorraine V Kalia, Suneil K Kalia

Affiliations

  1. Krembil Research Institute, Toronto Western Hospital, University Health Network, 60 Leonard Avenue, Toronto, ON, Canada.
  2. Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, Canada.
  3. Faculty of Medicine, University of British Columbia, 317-2194 Health Sciences Mall, Vancouver, BC, Canada.
  4. Morton and Gloria Shulman Movement Disorders Clinic and The Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, Department of Medicine, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, ON, Canada.
  5. Division of Neurology, Department of Medicine and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 190 Elizabeth Street, Toronto, ON, Canada.
  6. Division of Neurosurgery, Department of Surgery, University of Toronto, 149 College Street, Toronto, ON, Canada.

PMID: 28913005 PMCID: PMC5585656 DOI: 10.1155/2017/5015307

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by the presence of pathological intracellular aggregates primarily composed of misfolded

References

  1. J Neurochem. 2007 Jun;101(6):1491-1504 - PubMed
  2. J Biol Chem. 2015 Mar 27;290(13):8447-56 - PubMed
  3. Mov Disord. 2007 Oct 15;22(13):1962-4 - PubMed
  4. PLoS One. 2011 Feb 16;6(2):e14695 - PubMed
  5. Cell Stress Chaperones. 2009 Jan;14(1):105-11 - PubMed
  6. Nature. 2013 Dec 12;504(7479):291-5 - PubMed
  7. Mov Disord. 2015 Oct;30(12):1639-47 - PubMed
  8. Perspect Medicin Chem. 2007 Dec 11;1:39-48 - PubMed
  9. Neurobiol Aging. 2013 Nov;34(11):2694.e19-20 - PubMed
  10. J Mol Biol. 2005 Sep 2;351(5):1081-100 - PubMed
  11. Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9 - PubMed
  12. J Pharmacol Exp Ther. 2010 Mar;332(3):849-57 - PubMed
  13. Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31 - PubMed
  14. Nat Cell Biol. 2001 Jan;3(1):100-5 - PubMed
  15. EMBO J. 2012 Nov 5;31(21):4221-35 - PubMed
  16. J Biol Chem. 2005 Jun 24;280(25):23727-34 - PubMed
  17. J Mol Neurosci. 2015 Mar;55(3):587-95 - PubMed
  18. Lancet. 2015 Aug 29;386(9996):896-912 - PubMed
  19. J Biol Chem. 2013 Jun 14;288(24):17579-88 - PubMed
  20. Nat Rev Drug Discov. 2011 Dec 01;10(12):930-44 - PubMed
  21. Brain Res. 2003 Dec 12;993(1-2):133-9 - PubMed
  22. Ageing Res Rev. 2017 May;35:155-175 - PubMed
  23. Trends Biochem Sci. 2007 Aug;32(8):372-80 - PubMed
  24. Cell Death Dis. 2014 Apr 17;5:e1180 - PubMed
  25. Structure. 2010 Mar 10;18(3):309-19 - PubMed
  26. Cell. 1998 Aug 21;94(4):471-80 - PubMed
  27. Hum Mol Genet. 2014 Apr 1;23 (7):1794-801 - PubMed
  28. J Biol Chem. 2005 Dec 2;280(48):39962-9 - PubMed
  29. Cell. 1998 Feb 6;92(3):351-66 - PubMed
  30. Biochem J. 2017 Apr 24;474(9):1547-1558 - PubMed
  31. Mol Ther. 2005 Jan;11(1):80-8 - PubMed
  32. Mol Cell. 2015 Sep 3;59(5):781-93 - PubMed
  33. Curr Biol. 1999 Apr 22;9(8):R305-8 - PubMed
  34. Genes Dev. 1998 Dec 15;12(24):3788-96 - PubMed
  35. Onco Targets Ther. 2015 Jul 24;8:1849-58 - PubMed
  36. Science. 2002 Feb 1;295(5556):865-8 - PubMed
  37. Am J Physiol Cell Physiol. 2016 May 1;310(9):C755-63 - PubMed
  38. Front Aging Neurosci. 2014 Oct 08;6:268 - PubMed
  39. Mol Ther. 2014 Mar;22(3):487-97 - PubMed
  40. J Biol Chem. 2008 Sep 19;283(38):26188-97 - PubMed
  41. CNS Neurol Disord Drug Targets. 2010 Dec;9(6):741-53 - PubMed
  42. Nat Genet. 1994 Oct;8(2):148-54 - PubMed
  43. Acta Neuropathol Commun. 2013 Dec 05;1:79 - PubMed
  44. Front Mol Biosci. 2015 Oct 09;2:57 - PubMed
  45. Cell Death Dis. 2013 Mar 14;4:e545 - PubMed
  46. Curr Opin Chem Biol. 2010 Jun;14(3):412-20 - PubMed
  47. BMC Neurosci. 2009 Sep 01;10 :109 - PubMed
  48. PLoS One. 2008 Apr 02;3(4):e1884 - PubMed
  49. J Biol Chem. 2008 Jun 27;283(26):17962-8 - PubMed
  50. Science. 1997 Jun 27;276(5321):2045-7 - PubMed
  51. Science. 2003 Oct 31;302(5646):841 - PubMed
  52. J Biol Chem. 2015 Dec 18;290(51):30441-52 - PubMed
  53. Nat Med. 1998 Nov;4(11):1318-20 - PubMed
  54. Hum Gene Ther. 1999 Jan 20;10(2):201-13 - PubMed
  55. EMBO Rep. 2001 Dec;2(12 ):1133-8 - PubMed
  56. Neurotherapeutics. 2014 Oct;11(4):840-56 - PubMed
  57. J Neurochem. 2002 Nov;83(4):846-54 - PubMed
  58. Mol Neurobiol. 2016 May;53(4):2258-68 - PubMed
  59. Science. 1982 Sep 24;217(4566):1214-22 - PubMed
  60. Brain. 2014 Mar;137(Pt 3):834-48 - PubMed
  61. Mol Ther. 2012 Jul;20(7):1327-37 - PubMed
  62. Brain. 2013 Jul;136(Pt 7):2130-46 - PubMed
  63. Mol Ther. 2014 Feb;22(2):329-37 - PubMed
  64. EMBO J. 1997 Oct 15;16(20):6209-16 - PubMed
  65. Front Neuroanat. 2017 Feb 10;11:2 - PubMed
  66. ACS Chem Biol. 2013 Jul 19;8(7):1460-8 - PubMed
  67. Exp Neurol. 2014 Nov;261:206-16 - PubMed
  68. J Neural Transm (Vienna). 2009 Oct;116(10):1289-93 - PubMed
  69. Hum Mol Genet. 2010 Nov 15;19(22):4437-52 - PubMed
  70. Brain Res. 2014 Feb 10;1546:46-52 - PubMed
  71. ScientificWorldJournal. 2014;2014:938348 - PubMed
  72. Biochem Biophys Res Commun. 2011 Jun 24;410(1):114-20 - PubMed
  73. Science. 2004 Aug 27;305(5688):1292-5 - PubMed
  74. Arch Neurol. 2010 Dec;67(12):1464-72 - PubMed
  75. Genes (Basel). 2017 Feb 08;8(2): - PubMed
  76. Hum Genet. 2004 Feb;114(3):236-41 - PubMed
  77. Ann Neurol. 2013 Feb;73(2):155-69 - PubMed
  78. EMBO J. 1997 Apr 1;16(7):1501-7 - PubMed
  79. Front Neurosci. 2017 Apr 06;11:185 - PubMed
  80. J Clin Invest. 2008 Sep;118(9):3087-97 - PubMed
  81. Biochem Biophys Res Commun. 2004 Aug 27;321(3):665-9 - PubMed
  82. Oxid Med Cell Longev. 2017;2017:5094934 - PubMed
  83. Mov Disord. 2015 Nov;30(13):1830-4 - PubMed
  84. Brain. 2014 May;137(Pt 5):1481-95 - PubMed
  85. Nat Rev Neurosci. 2010 Dec;11(12 ):791-7 - PubMed
  86. Mol Ther. 2006 Sep;14(3):316-27 - PubMed
  87. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2897-902 - PubMed
  88. Cell. 2014 Jan 16;156(1-2):170-82 - PubMed
  89. Biochem Biophys Res Commun. 2017 Jan 1;482(1):75-80 - PubMed
  90. Neuron. 2015 Jan 21;85(2):257-73 - PubMed
  91. Brain Res. 2015 Apr 16;1604:52-61 - PubMed
  92. J Biol Chem. 2004 Jun 11;279(24):25497-502 - PubMed
  93. Mov Disord. 2016 Feb;31(2):178-92 - PubMed
  94. Lancet Neurol. 2016 Jun;15(7):748-759 - PubMed
  95. J Biol Chem. 2010 Apr 30;285(18):13621-9 - PubMed
  96. CNS Neurosci Ther. 2014 Jan;20(1):50-8 - PubMed
  97. Hum Mol Genet. 2013 Jul 15;22(14 ):2829-41 - PubMed
  98. Acta Pharmacol Sin. 2000 Jul;21(7):613-6 - PubMed
  99. Neuron. 2004 Dec 16;44(6):931-45 - PubMed
  100. Nat Med. 2002 Nov;8(11):1185-6 - PubMed
  101. Lancet Neurol. 2006 Jun;5(6):525-35 - PubMed
  102. IDrugs. 2006 Nov;9(11):778-82 - PubMed
  103. J Control Release. 2016 Aug 10;235:72-81 - PubMed
  104. Mol Ther Methods Clin Dev. 2016 Jan 13;3:15051 - PubMed
  105. PLoS One. 2014 Jan 20;9(1):e86048 - PubMed
  106. Neuropharmacology. 2014 Apr;79:190-200 - PubMed
  107. Nat Med. 2004 Feb;10 (2):148-54 - PubMed
  108. Mol Cell. 2002 Jul;10 (1):55-67 - PubMed
  109. Ann Neurol. 2016 Nov;80(5):766-775 - PubMed
  110. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14524-9 - PubMed
  111. Neuropathol Appl Neurobiol. 2016 Jun;42(4):352-65 - PubMed
  112. Free Radic Res. 2005 Oct;39(10 ):1091-9 - PubMed
  113. Neurobiol Aging. 2015 Jun;36(6):2213-23 - PubMed

Publication Types